Chemed Corporation (NYSE:CHE) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Chemed Corporation (NYSE:CHE) has been assigned an average recommendation of “Moderate Buy” from the six ratings firms that are covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $574.25.

CHE has been the topic of several research reports. Royal Bank Of Canada lowered their target price on Chemed from $589.00 to $572.00 and set an “outperform” rating on the stock in a report on Monday, November 10th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research note on Wednesday, October 8th. Finally, Zacks Research raised shares of Chemed from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 30th.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the company’s stock in a transaction that occurred on Monday, November 24th. The stock was sold at an average price of $437.55, for a total value of $875,100.00. Following the sale, the chief executive officer owned 94,197 shares of the company’s stock, valued at approximately $41,215,897.35. This represents a 2.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.29% of the stock is owned by corporate insiders.

Institutional Trading of Chemed

Several institutional investors and hedge funds have recently made changes to their positions in CHE. JPMorgan Chase & Co. increased its position in Chemed by 122.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 499,968 shares of the company’s stock worth $223,856,000 after purchasing an additional 275,423 shares in the last quarter. William Blair Investment Management LLC boosted its stake in shares of Chemed by 13.6% during the 3rd quarter. William Blair Investment Management LLC now owns 385,124 shares of the company’s stock worth $172,435,000 after purchasing an additional 46,038 shares during the last quarter. Epoch Investment Partners Inc. grew its holdings in shares of Chemed by 29.4% during the third quarter. Epoch Investment Partners Inc. now owns 307,275 shares of the company’s stock worth $137,579,000 after buying an additional 69,878 shares in the last quarter. TD Asset Management Inc grew its holdings in shares of Chemed by 23.1% during the third quarter. TD Asset Management Inc now owns 301,831 shares of the company’s stock worth $135,142,000 after buying an additional 56,546 shares in the last quarter. Finally, Acadian Asset Management LLC raised its position in shares of Chemed by 69.3% in the second quarter. Acadian Asset Management LLC now owns 250,722 shares of the company’s stock valued at $122,056,000 after buying an additional 102,597 shares during the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Chemed Trading Down 1.1%

Shares of CHE opened at $444.30 on Friday. Chemed has a twelve month low of $408.42 and a twelve month high of $623.60. The firm has a market capitalization of $6.29 billion, a P/E ratio of 23.50, a PEG ratio of 2.16 and a beta of 0.44. The firm’s 50-day moving average is $434.16 and its two-hundred day moving average is $446.69.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 28th. The company reported $5.27 EPS for the quarter, missing the consensus estimate of $5.39 by ($0.12). The firm had revenue of $624.90 million for the quarter, compared to analysts’ expectations of $626.04 million. Chemed had a return on equity of 25.89% and a net margin of 11.02%.Chemed’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the firm earned $5.64 EPS. Chemed has set its FY 2025 guidance at 22.000-22.300 EPS. Analysts predict that Chemed will post 21.43 EPS for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, December 5th. Stockholders of record on Monday, November 17th were paid a dividend of $0.60 per share. This represents a $2.40 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date of this dividend was Monday, November 17th. Chemed’s dividend payout ratio (DPR) is 12.69%.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.